Design requirements for interfering particles to maintain coadaptive stability with HIV-1

Igor M Rouzine1, Leor S Weinberger

  • 1The Gladstone Institutes, San Francisco, California, USA.

Journal of Virology
|December 11, 2012
PubMed
Summary

Engineered defective interfering particles (DIPs) show promise for treating human immunodeficiency virus (HIV). Mathematical modeling suggests DIPs competing for capsids, not genome codimerization, offer evolutionary stability against HIV-1 evolution.